Momenta

Press Releases

All Releases
View Summary Momenta Pharmaceuticals Announces Date of Second Quarter 2015 Financial Results Conference Call and Webcast
Jul 21, 2015
PDF 13.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces CFO Retirement and Succession Plan
Jun 25, 2015
PDF 15.5 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Launch of Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Jun 18, 2015
PDF 16.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces CAFC Decision to Invalidate Remanded Teva Pharmaceuticals Patent in Daily COPAXONE(R) 20 mg Suit
Jun 18, 2015
PDF 15.8 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Oral and Poster Presentations Relating to Novel Autoimmune Programs at EULAR 2015
Jun 4, 2015
PDF 18.6 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Present New Data From Phase 1 Trial of Necuparanib in Patients With Pancreatic Cancer
Jun 1, 2015
PDF 71.3 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
May 26, 2015
PDF 12.9 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock
May 19, 2015
PDF 13.0 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 18, 2015
PDF 13.0 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Data Presentation on Necuparanib (M402) at the 2015 ASCO Annual Meeting
May 18, 2015
PDF 14.9 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at the UBS 2015 Global Healthcare Conference
May 12, 2015
PDF 12.9 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at the Bank of America Merrill Lynch 2015 Health Care Conference
May 6, 2015
PDF 12.9 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Webcast Presentation at the Deutsche Bank 40th Annual Health Care Conference
May 1, 2015
PDF 12.9 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Reports First Quarter 2015 Financial Results
May 1, 2015
PDF 28.5 KB Add to Briefcase
View Summary Momenta Presents Key Glatopa(TM) (glatiramer acetate injection) Data at American Academy of Neurology Annual Meeting
Apr 20, 2015
PDF 16.8 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Data Presentations on Glatopa(TM) (glatiramer acetate injection) at the American Academy of Neurology's (AAN) 2015 Annual Meeting
Apr 17, 2015
PDF 14.8 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Conference Call Details Regarding FDA Approval for Glatopa(TM) (glatiramer acetate injection)
Apr 16, 2015
PDF 16.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces FDA Approval of ANDA for Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Apr 16, 2015
PDF 20.8 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Date of First Quarter 2015 Financial Results Conference Call and Webcast
Apr 15, 2015
PDF 13.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Publication Revealing Development of a Novel Process to Generate High-Quality Hyper-sialylated IVIg Drug Candidate in PNAS
Mar 2, 2015
PDF 17.5 KB Add to Briefcase
Showing 1-20 of 340 Page: 1 2 3 4 5 ... 17  Next 20
Add to Briefcase = add release to Briefcase